Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 61 to 75 of 132 results for cbt

  1. People who choose not to take antipsychotic medication:- What is the clinical and cost effectiveness of psychological intervention alone, compared with treatment as usual, in people with psychosis or schizophrenia who choose not to take antipsychotic medication?

    or lack of efficacy. There is evidence that psychological interventions (CBT and family intervention) as an adjunct to antipsychotic...

    Research recommendation
    Published
    9 June 2015

  2. Combined interventions for adults with social anxiety disorder:- What is the clinical and cost effectiveness of combined psychological and pharmacological interventions compared with either intervention alone in the treatment of adults with social anxiety disorder?

    Why this is important:- There is evidence for the effectiveness of both CBT and medication, in particular SSRIs, in the treatment of...

    Research recommendation
    Published
    9 June 2015

  3. Science policy and methods projects

    Science policy projects with NICE.

  4. Cognitive behavioural therapy for people with atrial fibrillation: What is the clinical and cost effectiveness of cognitive behavioural therapy compared with usual care for people with newly diagnosed atrial fibrillation?

    Cognitive behavioural therapy for people with atrial fibrillation: What is the clinical and cost effectiveness of cognitive...

    Research recommendation
    Published
    10 August 2021

  5. Prioritisation board decisions 2025

    Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.

  6. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence (CG115)

    This guideline covers identifying, assessing and managing alcohol-use disorders (harmful drinking and alcohol dependence) in adults and young people aged 10 to 17 years. It aims to reduce harms (such as liver disease, heart problems, depression and anxiety) from alcohol by improving assessment and setting goals for reducing alcohol consumption.

    Clinical guideline
    Last updated
    21 October 2014
    View recommendations

    Sections for CG115

  7. Medicines associated with dependence or withdrawal symptoms. Patient decision aid full version on should I stop my benzodiazepine or z-drug?

    groups near you. They may also suggest you think about group cognitive behavioural therapy (CBT). This is a talking...

  8. High-throughput non-invasive prenatal testing for fetal RHD genotype (HTG420)

    Evidence-based recommendations on high-throughput non-invasive prenatal testing (NIPT) for fetal RHD genotype.

    HealthTech guidance
    Published
    9 November 2016
    View recommendations

    Sections for HTG420

  9. Eating disorders (QS175)

    This quality standard covers assessment, treatment, monitoring and care for children, young people and adults with an eating disorder. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    21 September 2018
    View quality statements

    Sections for QS175

  10. What is the comparative clinical and cost effectiveness of pharmacological and psychosocial interventions for anxiety disorders in autistic children and young people?

    young people? Any explanatory notes(if applicable) Early trials of CBT for anxiety in autistic children and young people have been...

    Research recommendation
    Published
    10 August 2021

  11. The role of parents in the treatment of children and young people with social anxiety disorder:- What is the best way of involving parents in the treatment of children and young people (at different stages of development) with social anxiety disorder?

    should be tested using an RCT design with standard care (for example, group CBT) as the comparison. It should report short- and...

    Research recommendation
    Published
    9 June 2015

  12. Bipolar disorder, psychosis and schizophrenia in children and young people (QS102)

    This quality standard covers recognition, early intervention and long-term management of bipolar disorder, psychosis and schizophrenia in children and young people (under 18). It also includes support for parents and carers. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    15 October 2015
    View quality statements

    Sections for QS102

  13. Psychosis and schizophrenia in adults (QS80)

    This quality standard covers treating and managing psychosis and schizophrenia in adults (aged 18 and over) in primary, secondary and community care. It also includes support for the families and carers of people with psychosis or schizophrenia. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    12 February 2015
    View quality statements

    Sections for QS80

  14. Esketamine nasal spray for treatment-resistant depression (TA854)

    Evidence-based recommendations on esketamine (Spravato) for treatment-resistant depression in adults.

    Technology appraisal guidance
    Published
    14 December 2022
    View recommendations

    Sections for TA854

  15. Psychological interventions for children and young people with internalising disorders:- For children and young people with learning disabilities, what psychological interventions (such as cognitive behavioural therapy and interpersonal therapy) are clinically and cost effective for treating internalising disorders?

    learning disabilities, what psychological interventions (such as cognitive behavioural therapy and interpersonal therapy) are clinically...

    Research recommendation
    Published
    17 October 2016